Odborné materiály – Meniérova choroba

Antisekreční faktor (AF) – klinická inovace v Meniérově chorobě

Lange S. and Lönnoroth I.
The Antisecretory Factor: Synthesis, Anatomical and Cellular Distribution, and Biological Action in Experimental and Clinical Studies.
International Review of Cytology 2001; 210:39-75.

Jennische E, Hanson LÅ, Hansson H-A, Johansson E, Lönnroth I, Lange S.
Antisecretory factor and its biological activities.
Old Herborn University Seminar Monograph 22:
Biological consequences of host-microbe interactions.
Editors: Heidt PJ, Hanson LÅ,Tlaskalová H, Ruschv.
Old Herborn University Foundation, Herborn-Dill, Germany: 93-103 (2009)

Ulgheri K, Paganini B, Rossi F.
Antisecretory factor as a potential health-promoting molecule in man and animals.
Nutrition Research Reviews 2010; 23:300-313.

SPC-Flakes^Ⓡ při Meniérově chorobě – klinické studie:

1. Hanner P, Jennische E, Lange S, Lönnroth I, Wahlström B. Increased antisecretory factor reduces vertigo in patients with Ménière’s disease: a pilot study. Hearing Research 2004 Apr; 190(1-2):31- 36.
2. Hanner P, Rask-Andersen H, Lange S, Jennische E.
   Antisecretory factor-inducing therapy improves the clinical outcome in patients with Meniere’s disease.
   Acta Otolaryngologica 2010; 130:223-227.
3. Leong SC, Narayan S, Lesser TH.
   Antisecretory Factor–Inducing Therapy Improves Patient-Reported Functional Levels in Meniere’s Disease.
   Annals of Otology, Rhinology & Laryngology 2013; 122(10):619-624.
4. Scarpa A, Ralli M, Viola P, Cassandro C, Alicandri-Ciufelli M, Iengo M, Chiarella G, de Vincentiis M, Cavaliere M, Cassandro E.
   Food-induced stimulation of the antisecretory factor to improve symptoms in Meniere’s disease: our results.
   Eur Arch Otorhinolaryngol. 2020 Jan; 277(1):77-83.
5. Viola P, Pisani D, Scarpa A, Cassandro C, Laria C, Aragona T, Ciriolo M, Spadera L, Ralli M, Cavaliere M, Iengo M, Chiarella G.
   The role of endogenous Antisecretory Factor (AF) in the treatment of Ménière’s Disease: A two- year follow-up study. Preliminary results.
   Am J Otolaryngol. 2020 Nov-Dec; 41(6):102673.

Salovum^Ⓡ při Meniérově chorobě – kazuistika:

1. Hanner P, Jennische E, Lange S.
   Antisecretory Factor: A clinical innovation in Ménières Disease.
   Acta Otolaryngologica 2003; 123:779-780.

1. Björck S, Bosaeus I, Ek E, Jennische E, Lönnroth I, Johansson E, Lange S.
   Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: a study of a concept.
   Gut 2000; 46:824-829.
   

Crohnova choroba

1. Lange S, Bosaeus I, Jennische E, Johansson E, Lundgren BK, Lönnroth I.
   Food-induced antisecretory factor activity is correlated with small bowel length in patients with intestinal resections.
   APMIS 2003;111:985–988.
   

Syndrom dráždivého tračníku

1. Ekesbo R, Nilsson PM, Sjölund K.
   Effects of anti-secretory factor (ASF) on irritable bowel syndrome (IBS).
   Scand J Prim Health Care 2008; 26(2):106-110.
   

Ulcerativní colitida a Crohnova choroba – kazuistika

1. Finkel Y, Bjarnsson I, Lindblad A, Lange S.
   Specially processed cereals: A clinical Innovation for Children from Inflammatory Bowel Disease?
   Scand J Gastroenterol 2004; 39:87-88.
   

Salovum^Ⓡ při zánětlivých a sekrečních střevních onemocněních – klinické studie:
Ulcerativní colitida

1. Eriksson A, Shafazand M, Jennische E, Lange S.
   Effect of antisecretory factor in ulcerative colitis on histological and laborative outcome: a short period clinical trial.
   Scand J Gastroenterol 2003 Oct; 38(10):1045-1049.
   

Průjem u dětí

1. Laurenius A, Waşngberg B, Zaman S, Khalida Aamir K, Lange S, Jennische E, Silfverdal S-A, Hanson LA.
   Antisecretory factor effectively and safely stops childhood diarrhoea: a placebo-controlled, randomised study.
   Acta Peadiatrica 2014; 103:659-664.
   

SPC-Flakes^Ⓡ Salovum^Ⓡ při zánětlivých a sekrečních střevních onemocněních – klinické studie, poster a kazuistika:
Průjem způsobený karcinomem

1. Laurenius A, Waşngberg B, Lange S, Jennische E, Lundgren BK, Bosaeus I.
   Antisecretory factor counteracts secretory diarrhoea of endocrine origin.
   Clinical Nutrition 2003; 22(6):549–552.
   

Crohnova choroba – kazuistika

1. Eriksson A, Shafazand M, Jennische E, Lönnroth I, Lange S.
   Antisecretory factor-induced regression of Crohn’s disease in a weak responder to conventional pharmacological treatment.
   Inflamm Bowel Dis 2003 Nov; 9(6):398-400.
   

Interview – Dr Tomanovic Tatjana

KS Meniére care program

MiniSymposium Introduction Jan Bruhn Rome 2015

MiniSymposium Abstract Rome 2015

MiniSymposium Rome 2015 Summary